Intense Suicidal Thoughts and Self-Harm Following Escitalopram Treatment

Khan, Farooq; Bernadt, Morris
January 2011
Indian Journal of Psychological Medicine;Jan-Jun2011, Vol. 33 Issue 1, p74
Academic Journal
Case Study
In a minority of depressed patients, treatment with an antidepressant drug appears to initiate intense suicidal thoughts and actions. We describe this phenomenon in a 52-year-old woman treated with escitalopram. She did not experience this when treated with six other antidepressants, which were not Selective Serotonin Reuptake Inhibitors. Clinicians need to warn patients and their relatives of the risk that intense suicidal thoughts may develop after an antidepressant drug is started and encourage them to seek help immediately should this occur.


Related Articles

  • Genital self-mutilation. Ajape, A. A.; Issa, B. A.; Buhari, O. I. N.; Adeoye, P. O.; Babata, A. L.; Abiola, O. O. // Annals of African Medicine;2010, Vol. 9 Issue 1, p31 

    We present a case report of a 22-year-old Nigerian student who presented to the accident and emergency unit of a Nigerian Teaching Hospital with a history of self-inflicted genital injury following a suicide attempt. He had background history of predisposition to depressive illness, a current...

  • Antidepressants and Suicidality in Youth: Reflections From Adult Mood Disorder Specialists. Dago, Pedro; Gilmer, William S. // Behavioral Health Management;Jan/Feb2004, Vol. 24 Issue 1, pS3 

    Deals with antidepressants and suicidality in youth. Information on the balance of risks and benefits for the treatment of major depressive disorder; Analysis of several antidepressant drugs; Increased incidence of bipolar illness in early-onset depressions.

  • Antidepressants and suicidality. Lader, Malcolm // Clinical Risk;May2007, Vol. 13 Issue 3, p85 

    The acceptability of antidepressants among both professionals and the lay public, including depressed patients, has been set back by insistent reports of an enhanced suicidal risk. This encompasses suicidal ideas, intention, attempts and completed acts. Such behaviour is an intrinsic feature of...

  • Suicide and antidepressants: The latest chapter.  // Contemporary Pediatrics;Feb2007, Vol. 24 Issue 2, p12 

    The article presents updates on the controversy surrounding the labeling of antidepressant medications. Advocates of warning labels are convinced that labels should warn patients that antidepressant medications increase the risk of suicide. Those who oppose the warning label fear it will...

  • Self-harm by teenagers. Colman, Adrian // Youth Studies Australia;Spring1994, Vol. 13 Issue 3, p11 

    Focuses on the results of study on self-harm by teenagers conducted by the Centre for Adolescent Health at the Royal Children's Hospital in Melbourne, Australia. Percentage of males and females 15-16 years of age who attempted to harm themselves; Lack of awareness of the problem.

  • Cut it out. Valley, Jody // Between the Lines (10807551);6/16/2011, Issue 1924, p28 

    The article provides an answer to a question on dealing with the issue of a girlfriend who is cutting herself.

  • Use of antidepressants among people committing suicide in Sweden. Isacsson, Goran; Holmgren, Per; Wasserman, Danuta; Bergmen, Ulf // BMJ: British Medical Journal (International Edition);2/19/94, Vol. 308 Issue 6927, p506 

    Analyzes the suicidal behavior and outcome of depression in Sweden. Detection of antidepressants in the national forensic toxicological screening programs of unnatural deaths; Efforts of the National Laboratory of Forensic Chemistry in the detection of antidepressants; Discussions on the result...

  • Gene clue to male suicide risk. Liddle, Rachel // GP: General Practitioner;6/8/2007, p2 

    The article presents information related to a study which has revealed that a gene mutation has been linked to a threefold increase in the risk of suicidal tendencies among men taking antidepressants. According to the study which has been conducted in the U.S., changes to a gene encoding cyclic...

  • Depression Update.  // PharmaWatch: CNS;Jan2006, Vol. 5 Issue 1, p14 

    The article presents news related to depression treatment. The United States Food and Drug Administration has delayed its decision for three months on whether or not to approve Somerset Pharmaceuticals Inc.'s product candidate Emsam, a transdermal patch for the treatment of major depressive...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics